744 related articles for article (PubMed ID: 10021471)
1. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.
Buckley RH; Schiff SE; Schiff RI; Markert L; Williams LW; Roberts JL; Myers LA; Ward FE
N Engl J Med; 1999 Feb; 340(7):508-16. PubMed ID: 10021471
[TBL] [Abstract][Full Text] [Related]
2. Haploidentical bone marrow stem cell transplantation in human severe combined immunodeficiency.
Buckley RH; Schiff SE; Schiff RI; Roberts JL; Markert ML; Peters W; Williams LW; Ward FE
Semin Hematol; 1993 Oct; 30(4 Suppl 4):92-101; discussion 102-4. PubMed ID: 7905667
[TBL] [Abstract][Full Text] [Related]
3. Thymic function after hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.
Patel DD; Gooding ME; Parrott RE; Curtis KM; Haynes BF; Buckley RH
N Engl J Med; 2000 May; 342(18):1325-32. PubMed ID: 10793165
[TBL] [Abstract][Full Text] [Related]
4. Development of immunity in human severe primary T cell deficiency following haploidentical bone marrow stem cell transplantation.
Buckley RH; Schiff SE; Sampson HA; Schiff RI; Markert ML; Knutsen AP; Hershfield MS; Huang AT; Mickey GH; Ward FE
J Immunol; 1986 Apr; 136(7):2398-407. PubMed ID: 2869085
[TBL] [Abstract][Full Text] [Related]
5. T cell depleted haploidentical bone marrow transplantation for the treatment of children with severe combined immunodeficiency.
Smogorzewska EM; Brooks J; Annett G; Kapoor N; Crooks GM; Kohn DB; Parkman R; Weinberg KI
Arch Immunol Ther Exp (Warsz); 2000; 48(2):111-8. PubMed ID: 10807052
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes of nonconditioned patients with severe combined immunodeficiency transplanted with HLA-identical or haploidentical bone marrow depleted of T cells with anti-CD6 mAb.
Patel NC; Chinen J; Rosenblatt HM; Hanson IC; Brown BS; Paul ME; Abramson SL; Ritz J; Shearer WT
J Allergy Clin Immunol; 2008 Dec; 122(6):1185-93. PubMed ID: 19084111
[TBL] [Abstract][Full Text] [Related]
7. Related HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: observations of a single Chinese center.
Huang X; Liu D
Clin Transpl; 2011; ():237-45. PubMed ID: 22755417
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
[TBL] [Abstract][Full Text] [Related]
9. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype.
Aversa F; Tabilio A; Velardi A; Cunningham I; Terenzi A; Falzetti F; Ruggeri L; Barbabietola G; Aristei C; Latini P; Reisner Y; Martelli MF
N Engl J Med; 1998 Oct; 339(17):1186-93. PubMed ID: 9780338
[TBL] [Abstract][Full Text] [Related]
10. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources.
Rocha V; Wagner JE; Sobocinski KA; Klein JP; Zhang MJ; Horowitz MM; Gluckman E
N Engl J Med; 2000 Jun; 342(25):1846-54. PubMed ID: 10861319
[TBL] [Abstract][Full Text] [Related]
11. Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft.
Horwitz ME; Barrett AJ; Brown MR; Carter CS; Childs R; Gallin JI; Holland SM; Linton GF; Miller JA; Leitman SF; Read EJ; Malech HL
N Engl J Med; 2001 Mar; 344(12):881-8. PubMed ID: 11259721
[TBL] [Abstract][Full Text] [Related]
12. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients.
Kurtzberg J; Laughlin M; Graham ML; Smith C; Olson JF; Halperin EC; Ciocci G; Carrier C; Stevens CE; Rubinstein P
N Engl J Med; 1996 Jul; 335(3):157-66. PubMed ID: 8657213
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow transplantation for T-B- severe combined immunodeficiency disease in Athabascan-speaking native Americans.
O'Marcaigh AS; DeSantes K; Hu D; Pabst H; Horn B; Li L; Cowan MJ
Bone Marrow Transplant; 2001 Apr; 27(7):703-9. PubMed ID: 11360109
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow 'boosts' following T cell-depleted haploidentical bone marrow transplantation.
Kline RM; Stiehm ER; Cowan MJ
Bone Marrow Transplant; 1996 Apr; 17(4):543-8. PubMed ID: 8722352
[TBL] [Abstract][Full Text] [Related]
15. Haploidentical peripheral blood and marrow stem cell transplantation in nine cases of primary immunodeficiency.
Lanfranchi A; Verardi R; Tettoni K; Neva A; Mazzolari E; Pennacchio M; Pasic S; Ugazio AG; Albertini A; Porta F
Haematologica; 2000 Nov; 85(11 Suppl):41-6. PubMed ID: 11268323
[TBL] [Abstract][Full Text] [Related]
16. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
17. Haploidentical peripheral blood stem cell transplantation with a combination of CD34 selection and T cell depletion as graft-versus-host disease prophylaxis in a patient with severe combined immunodeficiency.
Martín-Hernández MP; Arrieta R; Martínez A; García P; Jimenez-Yuste V; Hernandez-Navarro F
Bone Marrow Transplant; 1997 Nov; 20(9):797-9. PubMed ID: 9384486
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic bone marrow transplantation: relation between chimaerism and immunity.
Vossen J
Verh K Acad Geneeskd Belg; 1998; 60(2):111-43; discussion 143-5. PubMed ID: 9703764
[TBL] [Abstract][Full Text] [Related]
19. Serial transplantation resulting in tolerance to an unrelated cord blood graft.
Goebel WS; Nelson RP; Brahmi Z; Gowan DJ; Towell PJ; Robertson KA; Haut PR
Transplantation; 2006 Jun; 81(11):1596-9. PubMed ID: 16770250
[TBL] [Abstract][Full Text] [Related]
20. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
